ELI LILLY & Co
A research-based company that develops and sells pharmaceutical products.
LLY | US
Overview
Corporate Details
- ISIN(s):
- US5324571083
- LEI:
- Country:
- United States of America
- Address:
- LILLY CORPORATE CTR, 46285 INDIANAPOLIS
- Website:
- https://www.lilly.com/
- Sector:
- Manufacturing
Description
Eli Lilly and Company is a global, research-based medicine company that discovers, develops, manufactures, and sells pharmaceutical products. The company focuses on creating treatments in key therapeutic areas, including diabetes, obesity, immunology, oncology, and neuroscience. Leveraging biotechnology and chemistry, it develops medicines for some of the world's most significant health challenges. Historically known for the commercialization of insulin, the company continues to be a major provider of therapies for chronic diseases. Its stated purpose is to unite caring with discovery to create medicines that make life better for people around the world.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2016-12-13 00:43 |
Lilly Announces Dividend Increase
|
English | 2.0 KB | ||
| 2016-11-23 13:51 |
Lilly Announces Top-Line Results of Solanezumab Phase 3 Clinical Trial
|
English | 7.6 KB | ||
| 2016-10-25 15:04 |
Lilly Reports Third-Quarter 2016 Results
|
English | 52.2 KB | ||
| 2016-10-19 23:24 |
FDA Approves Lilly's LARTRUVO™ (olaratumab) in Combination with Doxorubicin for…
|
English | 17.8 KB | ||
| 2016-10-17 22:20 |
Lilly Declares Fourth-Quarter 2016 Dividend
|
English | 1.9 KB | ||
| 2016-10-05 14:20 |
Elanco Animal Health Enters Agreement to Acquire Boehringer Ingelheim Vetmedica…
|
English | 9.9 KB | ||
| 2016-08-31 13:45 |
Jamere Jackson Elected to Lilly Board of Directors
|
English | 3.1 KB | ||
| 2016-07-29 07:38 |
Eli Lilly and Company Files Form 10-Q
|
English | 1.6 KB | ||
| 2016-07-27 14:10 |
Eli Lilly and Company files a Form 8-K
|
English | 2.2 KB | ||
| 2016-07-27 13:45 |
John C. Lechleiter to Retire as Lilly CEO; Board Elects David A. Ricks as Succe…
|
English | 7.7 KB | ||
| 2016-07-26 18:28 |
Lilly Reports Second-Quarter 2016 Results, Provides Financial Expectations Thro…
|
English | 51.9 KB | ||
| 2016-07-26 14:50 |
Eli Lilly and Company Files a Form 8-K
|
English | 1.8 KB | ||
| 2016-06-20 20:29 |
Lilly Declares Third-Quarter 2016 Dividend
|
English | 1.8 KB | ||
| 2016-05-02 22:31 |
Lilly Declares Second-Quarter 2016 Dividend
|
English | 1.8 KB | ||
| 2016-04-29 21:54 |
Eli Lilly and Company Files Form 10-Q
|
English | 1.6 KB |
Automate Your Workflow. Get a real-time feed of all ELI LILLY & Co filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ELI LILLY & Co
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ELI LILLY & Co via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
